A Patient-Centered Pragmatic Clinical Trial

Joined March 2016
303 Photos and videos
Pinned Tweet
#ACC21 @ACCinTouch Sharing What We Learned | @PCORI-funded #ADAPTABLEstudy team led by @DCRINews is committed to sharing results with participants. Read our #plainlanguage summary & watch a Town Hall recording featuring patient partners at theaspirinstudy.org @PCORnetwork
1
48
96
In case you missed it, see below for a Q & A with @DCRINews @texhern about the @PCORI-funded #ADAPTABLEstudy @PCORnetwork πŸ‘‡
The @ADAPTABLEstudy might be completed, but DCRI’s learnings & secondary analyses are not. Read a Q&A w/ DCRI Exec Dir @texhern to learn about how the demonstration project for @PCORnetwork creates a launch pad for future #clinicalresearch with #EHRs: bit.ly/2RweFb2
3
5
What to learn more about #ADAPTABLEstudy? Read below πŸ‘‡
How did DCRI design the @ADAPTABLEstudy, the landmark pragmatic trial to determine the right dose of aspirin for people with #heartdisease? Read a Q&A with DCRI Executive Director @texhern: bit.ly/2RweFb2 @PCORnetwork @PCORI #EHRs
4
#ClinicalTrialsDay | Today we honor and thank the patient partners, clinicians, researchers, and the more than 15,000 study participants who volunteered in the #ADAPTABLEstudy to help advance the care of people with #heartdisease. #CTD2021 | theaspirinstudy.org @PCORI
4
11
On #ClinicalTrialsDay, lessons from @PCORI-funded #ADAPTABLEstudy can help inform the future of #ClinicalResearch from how we engage with patients and clinicians, to leveraging #EHR, and sharing our results with the community. @texhern @schuyler_jones @DCRINews @PCORnetwork πŸ‘‡
DCRI-led @ADAPTABLEstudy presented results at #ACC21 this past weekend. Read a Q&A with DCRI Executive Director @texhern about what we learned from this landmark study conducted with @PCORnetwork: bit.ly/2RweFb2
2
8
Via @DCRINews learn more about the @PCORI-funded #ADAPTABLEstudy and how patient partners and clinicians were involved. Visit theaspirinstudy.org #pragmatictrials @PCORnetwork

"We chose outcomes that were important to patients and clinicians alike," DCRI's @schuyler_jones says while sharing additional insights on @ADAPTABLEstudy during an #ACC21 deep dive.
3
Via @CMichaelGibson | Another example of how patient partners in the @PCORI-funded #ADAPTABLEstudy continue to transform #ClinicalTrials and provide a model for the future. @patientispard @schuyler_jones @DCRINews @PCORnetwork
This is the FIRST TIME we have had a participant in a trial present the background for why the study was done and the primary results!
1
11
#ACC21 @ACCinTouch #LBCT | @schuyler_jones of @DCRINews says partnering with patients in the @PCORI-funded #ADAPTABLEstudy provided opportunities to co-create research that keeps participants at the center of the conversation. @PCORnetwork
7
Presented at #ACC21 @ACCinTouch & published in @NEJM | @schuyler_jones with @DCRINews @DukeMedSchool shares results from @PCORI-funded #ADAPTABLEstudy, a #randomizedcontrolledtrial through @PCORnetwork. Watch:
4
22
Role of the Research Patient Partner | @patientispard with @ThePaTHNetwork shares what it meant to be an Adaptor in the @PCORI-funded #ADAPTABLEstudy and his vision for the future of #clinicaltrials. @PCORnetwork #patientengagement #ACC21 @ACCinTouch @DCRINews
3
8
#ACC21 @ACCinTouch | Research patient partners, Desiree Davidson @CAPriCORN_CDRN & @patientispard @ThePaTHNetwork discuss the #ADAPTABLEstudy results and how patient partners can transform #clinicaltrials with @schuyler_jones WATCH: youtu.be/11mvf0FgdVs @PCORI @PCORnetwork

2
The #ADAPTABLEstudy, the first #randomizedclinicaltrial of @PCORnetwork provides a model for #patientengagment, leveraging #EHR data, direct-to-participant methods, & participant-reported outcomes. Learn more: theaspirinstudy.org @PCORI @DCRINews

3
6
#ACC21 @ACCinTouch | Results from @PCORI-funded #ADAPTABLEstudy indicate lower- and higher-dose aspirin achieve similar protection and safety for people with #heartdisease. Read more about the results at theaspirinstudy.org @PCORnetwork @DCRINews @schuyler_jones
7
16
Happening now in today's #ACC21 #LBCT @schuyler_jones will present results from the #ADAPTABLEstudy.
In a trial designed to try to answer Q of optimal dose of #aspirin for secondary prev. in patients with established atherosclerotic #CVD, no significant diff. found in CV events/major bleeding btwn the 81 mg & 325 mg daily doses. bit.ly/3tRJKTH #ADAPTABLE #ACC21 @NEJM
2
5
Kick off your @ACCinTouch #ACC21 schedule with results from the @PCORI-funded #ADAPTABLEstudy, the first #randomizedcontrolledtrial through @PCORnetwork. πŸ‘‡
Welcome to the first day of #ACC21! We are excited to hear and present a lot of great science today, including late-breaking results from @adaptablestudy and a couple of interesting panel discussions. Stay tuned! bit.ly/3goxF5q
3
6
Attending virtual @ACCinTouch #ACC21? Don't miss the #LBCT session today at 9:00 am ET where @schuyler_jones will present results from the @PCORI-funded #ADAPTABLEstudy. @DCRINews @PCORnetwork
2
#ACC21 5/15, 9:00 am ET | Late-Breaking Clinical Trials, Session #402 | One more sleep until @schuyler_jones presents results from the #ADAPTABLEstudy. Please join us tomorrow @ACCinTouch @DCRINews @PCORI @PCORnetwork
12
22
Happening now @Collaboratory1 #pctGR | Looking forward to listening to this keynote conversation and the workshop series on improving diversity in #pragmatictrials.
πŸ“£ Starting now on PCT Grand Rounds! "Diverse Representation Among Clinical Trial Participants: Why It Is Important and How We Can Improve" with Dr. Clyde Yancy of @NUFeinbergMed. πŸ”— bit.ly/3uCLEss #pctGR
1
We could not have reached this point of sharing results on aspirin for people with #heartdisease without the #ADAPTABLEstudy patient partners. We invite you to meet the Adaptors who helped us think about research differently: theaspirinstudy.org/meet-the… @PCORnetwork @PCORI @DCRINews
4
15